Quantinuum publicly files S-1 with the SEC for a proposed Nasdaq IPO under ticker QNT, targeting >$20B valuation; Q1 2026 revenue disclosed at $5.2M from $19.1M YoY
On 2026-05-08 (Friday), Honeywell announced that Quantinuum, a leading full-stack quantum computing company majority-owned by Honeywell, has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering of Class A common stock on the Nasdaq Global Select Market under the proposed ticker symbol 'QNT'. Per the Honeywell press release issued via PR Newswire at 20:11 UTC and per Reuters reporting (Arasu Kannagi Basil), the number of shares to be offered and the price range for the proposed offering have not yet been determined. J.P. Morgan and Morgan Stanley are acting as joint lead active book-running managers; Jefferies and Evercore ISI are also acting as active book-running managers. The S-1 transitions Quantinuum's IPO from the confidential submission stage (originally filed 2026-02-17 per Honeywell's 2026-04-23 Q1 earnings disclosure) to public registration, making detailed financial disclosures available for the first time. According to the S-1 financial disclosures as reported by Reuters, Seeking Alpha, and TheNextWeb, Quantinuum reported a net loss of $192.6M on revenue of $30.9M for the fiscal year ended 2025-12-31 (compared with $144.1M loss on $23.0M revenue the prior year, ~34% revenue YoY growth). The S-1 also discloses Q1 2026 results: revenue dropped sharply to $5.2M from $19.1M in the prior-year quarter, while net loss climbed to $136.6M from $30.5M. Trade-press reporting (TheNextWeb, IPOX) cites a target valuation above $20B, which would represent a doubling from the $10B pre-money valuation at which Quantinuum raised $600M in September 2025. Honeywell stated separately that it expects to deconsolidate Quantinuum's results beginning in Q2 2026.
Score 8 — anchor row 8.2 band-7 'unexpected corporate action at a tracked public company' is exceeded by Quantinuum's pure-play quantum positioning and >$20B target valuation, which puts this above the typical 7-anchor for a single-public-company corporate action. Quantinuum is the largest pure-play quantum-computing company by trailing revenue ($30.9M FY2025) and would, if priced near the reported >$20B target, become the highest-valued public quantum-computing pure-play by an order of magnitude over IonQ, Rigetti, D-Wave, QuantumComputing Inc., and the Xanadu de-SPAC trading debut anchor (priced at $3.1B in March 2026, scored 8 in /daily/2026-03-27.json). Held below score 9 because the offering has not yet priced and the registration statement has not yet become effective — the listing remains 'subject to market conditions, and there can be no assurance as to whether or when the offering may be completed' per the Honeywell press release; close-call rounds DOWN per CLAUDE.md. The §16 open-thread 'Quantinuum IPO pending' explicitly anchors this at the score-9 threshold ONLY for a priced listing; today's S-1 public filing is the precursor disclosure event, not the priced offering. Per CLAUDE.md hard rule 10, this score-7+ public-company event is corroborated against the SEC EDGAR primary filing (CIK 0002110105, accession 0001628280-26-032836) — Reuters and Honeywell press release both reference the SEC submission and the financial figures match.
The Q1 2026 financial deterioration disclosed in the S-1 is materially negative information not previously public: revenue down from $19.1M to $5.2M YoY (-73%) on a 4.4× expansion of net loss ($30.5M → $136.6M). For the largest pure-play quantum revenue name, this resets near-term comparable financials for IonQ ($64.7M Q1 2026 revenue, +755% YoY), Rigetti (Q1 2026 print pending), D-Wave (Q1 2026 pending), QUBT, and Arqit — IonQ's Q1 2026 revenue is now ~12.4× Quantinuum's most recent quarter. The IPO timing pressures peer pure-plays: priced IPO economics depend on whether the public market accepts the >$20B target framing despite declining QoQ revenue. Implications for the open thread 'Public-quantum dilution-overhang risk' (state.json open_threads): a >$20B Quantinuum priced listing would provide a positive anchor; a downward-revised pricing or delay would compound dilution-overhang concerns visible in the 2026-05-04 Xanadu 424B3 resale registration. For Honeywell shareholders, the planned Q2 2026 deconsolidation of Quantinuum (per Honeywell's 2026-04-23 Q1 commentary) becomes operationally relevant as the public listing approaches; the parent's quantum-computing exposure transitions from balance-sheet-consolidated to listed-equity stake (Honeywell expected to retain a majority stake post-IPO per Reuters). Trapped-ion modality positioning: this is the first IPO-priced trapped-ion pure-play to reach the public market, complementing the photonic (Xanadu, public March 2026), superconducting (Rigetti public via SPAC since 2022; D-Wave public via SPAC since 2022), and pre-IPO trapped-ion (IonQ public via SPAC since 2021) prior listings. Watch for: (a) registration-statement effectiveness date and IPO pricing (next typical step is preliminary prospectus / 'red herring' followed by roadshow); (b) whether the offering proceeds at the >$20B target or repriced lower given the Q1 2026 revenue decline; (c) lock-up structure design for Honeywell and pre-IPO investors; (d) IonQ's, Rigetti's, and D-Wave's public commentary on the Quantinuum disclosures during their respective May/June earnings cycles; (e) whether the Q1 2026 revenue drop reflects timing (system-sale recognition lumpiness) versus structural softening — the S-1 and prospectus when amended will clarify. Strengthens the open thread 'Quantinuum IPO pending' (now anchored at this event ID), advancing it from confidential-submission stage to public-registration stage. Pricing remains the score-9 trigger.